Streptococcus salivarius BLIS K12 and Reduced Incidence of Upper Respiratory Tract Infections

• Efficacy of Streptococcus salivarius Blis K12 in the Prevention of Upper Respiratory Tract Infections in Physically Active Individuals: A Randomized Controlled Trial.

  • 2024-10-26
  • RCT · n = 112
  • Microorganisms 12(11)
  • • Alexander Bertuccioli
    • Marco Cardinali
    • Matteo Micucci
    • Marco Bruno Luigi Rocchi
    • Chiara Maria Palazzi
    • Giordano Bruno Zonzini
    • Giosuè Annibalini
    • Annalisa Belli
    • Davide Sisti

  • PubMed: 39597553
  • DOI: 10.3390/microorganisms12112164

  2 Insights on

  • Reduced Incidence of Upper Respiratory Tract Infections

  • High evidence

  higher adherence to the S. salivarius K12 treatment was associated with an increased number of days without URTI symptoms. Although the overall severity of symptoms did not differ significantly between the treatment and control groups, those with high adherence to S. salivarius K12 (greater than 90%) reported more days free from illness.

  Effect

  Beneficial

  Effect size

  Small